Trial Outcomes & Findings for Self-Propelled Percutaneous Endoscopic GastroJejunostomy (PEG-J) (NCT NCT01551095)
NCT ID: NCT01551095
Last Updated: 2017-03-31
Results Overview
One week after the procedure patients were called by one of the study investigators and were asked whether or not they had Abdominal pain, Nausea or Vomiting after the procedure.
TERMINATED
PHASE2
7 participants
From date of PEGJ placement up to 3 weeks
2017-03-31
Participant Flow
Patients were enrolled between January 2012 and May 2012 in a tertiary academic center
Participant milestones
| Measure |
PEGJ
Patients in this arm will receive self-propelled balloon PEGJ tube.
PEGJ tube: The self-propelled PEGJ feeding tube
|
|---|---|
|
Overall Study
STARTED
|
7
|
|
Overall Study
COMPLETED
|
7
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Self-Propelled Percutaneous Endoscopic GastroJejunostomy (PEG-J)
Baseline characteristics by cohort
| Measure |
PEGJ
n=7 Participants
Patients in this arm will receive self-propelled balloon PEGJ tube.
PEGJ tube: The self-propelled PEGJ feeding tube
|
|---|---|
|
Age, Customized
|
38.3 years
n=5 Participants
|
|
Sex: Female, Male
Female
|
7 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: From date of PEGJ placement up to 3 weeksOne week after the procedure patients were called by one of the study investigators and were asked whether or not they had Abdominal pain, Nausea or Vomiting after the procedure.
Outcome measures
| Measure |
PEGJ
n=7 Participants
Patients in this arm will receive self-propelled balloon PEGJ tube.
PEGJ tube: The self-propelled PEGJ feeding tube
|
|---|---|
|
Safety: Number of Participants With Adverse Events
Abdominal Pain
|
1 participants
|
|
Safety: Number of Participants With Adverse Events
Nausea
|
0 participants
|
|
Safety: Number of Participants With Adverse Events
Vomiting
|
0 participants
|
SECONDARY outcome
Timeframe: From date of PEGJ placement up to 3 weeksAn Abdominal X-ray was obtained 3 weeks after the procedure to check whether or not there was any PEGJ feeding tube migration.
Outcome measures
| Measure |
PEGJ
n=7 Participants
Patients in this arm will receive self-propelled balloon PEGJ tube.
PEGJ tube: The self-propelled PEGJ feeding tube
|
|---|---|
|
Number of Participants With Retrograde Migration of PEGJ Feeding Tube Within 3 Weeks of Placement
|
0 participants
|
Adverse Events
PEGJ
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
PEGJ
n=7 participants at risk
Patients in this arm will receive self-propelled balloon PEGJ tube.
PEGJ tube: The self-propelled PEGJ feeding tube
|
|---|---|
|
Gastrointestinal disorders
Abdominal pain
|
14.3%
1/7 • Number of events 1
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place